Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
2021;13:eabj0716
Nomination, Category 1 status, an advisory committee vote, and final inclusion through regulation are separate stages and should not be described as interchangeable
Built for Your Situation Get a recovery plan built around your injury, your training, and your goals
These insulated cases are designed to store refrigerated medications while traveling
The biggest leaves of each treatment were harvested after 4 days HT treatment, and the samples were frozen immediately in liquid nitrogen and stored at 80 C for further analysis